title: A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
authors.forename: V
authors.initials: V
authors.lastname: Gebbia
authors.forename: A
authors.initials: A
authors.lastname: Testa
authors.forename: R
authors.initials: R
authors.lastname: Valenza
authors.forename: G
authors.initials: G
authors.lastname: Zerillo
authors.forename: S
authors.initials: S
authors.lastname: Restivo
authors.forename: F
authors.initials: F
authors.lastname: Ingria
authors.forename: G
authors.initials: G
authors.lastname: Cannata
authors.forename: N
authors.initials: N
authors.lastname: Gebbia
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D014747:Vinblastine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077235:Vinorelbine
chemical_list: D000970:Antineoplastic Agents; D014747:Vinblastine; D000077235:Vinorelbine